top of page
Protective Gear

COVID-19 Antibody Testing

Taking steps to help identify patient status

IgG antibody serology testing can give you the insights

The SARS-CoV-2 (COVID-19) IgG & IgM antibody serology test from Calibrex helps you understand if you have the antibody

  • A positive IgG result indicates the presence of antibodies to SARS-CoV-2 (COVID-19)

  • The IgG & IgM antibody serology test is one tool to help identify people who have been exposed to or overcame COVID-19

What's in the SARS-CoV2 (COVID-19) Rapid Test Kit?


Immunochromatographic Testing Device

25 pcs

COVID-19 IgG & IgM Rapid Test Kit


Test Buffer

1 Vial


Qty 25

QuikPac II

Qty 25

COVID-19 Testing Device

Qty 25

Covid 19
  • Calibrex Technologies is committed to providing safe, healthy work environments by following OHSA recommended guidelines and the FDA's Quality Systems Regulations and ISO 13485:2016 standards for medical device design and manufacturing

  • Understanding the risks of returning to work with COVID-19 is crucial in creating a safe work environment for your workers

Understanding COVID-19 And The Risks for Your Business

OHSA Guidelines for Preparing Workplaces for COVID-19

The following are steps all employers should take to reduce worker's risk of exposure to SARS-CoV-2 following OHSA recommended guidelines:


Develop an Infectious Disease Preparedness and Response Plan


Prepare to Implement Basic Infection Prevention Measures


Develop Policies and Procedures for Prompt Identification and Isolation of Sick People, if Appropriate


Develop, Implement, and Communicate about Workplace Flexibilities and Protections


Implement Workplace Controls and Follow Existing OHSA Standards and Guidelines

The SARS-CoV-2 (COVID-19) IgG & IgM Antibody Serology Test From Calibrex

Calibrex proudly distributes Syntron Bioresearch IgG & IgM rapid antibody serology tests for COVID-19 

Covid 19
  • ​Serology tests for SARS-CoV-2 help you understand who may have already had the COVID-19 virus​

  • Knowing whether your employees have had prior exposure can help you make informed decisions about getting back to daily routines

About SARS-CoV2 (COVID-19) Rapid Test Kit

It is widely accepted that IgM provides the first line of defense during viral infections, followed by the generation of adaptive, high affinity IgG responses for long term immunity and immunological memory. Testing of COVID-19 IgM and IgG antibodies is an effective method for the rapid diagnosis of COVID-19 infection. Detection of COVID-19 IgM antibodies to indicate a recent exposure to COVID-19, whereas detection of COVID-19 IgG antibodies indicates a later stage of infection. Thus, this combined antibody test could also provide information on the stage of infection.


It can be used for rapid screening of carriers of the virus that are symptomatic or asymptomatic. Recent studies suggest that a high percentage of patients show no clinical symptoms of the virus, thus screening patients is vitally important. The test is ideally suited for hospitals, clinics and test laboratories. The test can also be effectively deployed in businesses, schools, airports, seaports and train stations, etc., giving it the potential to become a compelling force in the fight against this global threat.

The SARS-CoV-2 (COVID-19) IgG & IgM antibody serology test from Calibrex helps you understand if you have the antibody

  • A positive IgG & IgM result indicates the presence of antibodies to SARS-CoV-2 (COVID-19). 

  • A negative IgG & IgM result means that the antibodies to the virus was not found in your sample. A negative result can also occur if you are tested early in your illness and your body has not had time to produce the antibodies.

  • Your healthcare provider will work with you to determine the best care based on your results.

  • We work with registered nurses to bring our Rapid COVID-19 Test Kit to your business minimizing your employee's exposure to the virus.

  • ​The IgG & IgM antibody serology test is the first rapid COVID-19 test and it is important to work with your healthcare provider upon being tested.

  • Test results are shown within 15 minutes.

The test was validated using 602 clinically positive and negative patient samples. The overall test sensitivity of QuikPacII™ COVID-19 IgG/IgM is 89.4% and specificity is 97.7%. • For Rx use only. • This test has not been reviewed by the FDA. For use in high complexity clinical laboratories by health care professionals following FDA guidance “Policy for Diagnostic Tests for Coronavirus Disease-2019 (COVID-19) during the Public Health Emergency”. • Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic assay should be considered to rule out infection in these individuals. • Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status. • Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E. • Not for the screening of donated blood.

Minimize the Unknown About COVID-19 with Calibrex Rapid Test Kit

Thanks for submitting!


Engineering & Manufacturing

Calibrex Technologies, Inc. 

9720 S. Virginia St. Suite B

Reno, NV 89511

bottom of page